| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| cellular component organization or biogenesis | 24 out of 39 genes, 61.5% | 180 out of 533 genes, 33.8% | 0.0002119728 |
| cellular component organization | 23 out of 39 genes, 59.0% | 169 out of 533 genes, 31.7% | 0.0002406854 |
| single-organism process | 34 out of 39 genes, 87.2% | 341 out of 533 genes, 64.0% | 0.0008177223 |
| regulation of response to biotic stimulus | 3 out of 39 genes, 7.7% | 4 out of 533 genes, 0.8% | 0.001382511 |
| myofibril assembly | 3 out of 39 genes, 7.7% | 4 out of 533 genes, 0.8% | 0.001382511 |
| actomyosin structure organization | 3 out of 39 genes, 7.7% | 4 out of 533 genes, 0.8% | 0.001382511 |
| actin filament-based process | 6 out of 39 genes, 15.4% | 19 out of 533 genes, 3.6% | 0.001393328 |
| actin cytoskeleton organization | 5 out of 39 genes, 12.8% | 15 out of 533 genes, 2.8% | 0.00283186 |
| positive regulation of leukocyte activation | 3 out of 39 genes, 7.7% | 5 out of 533 genes, 0.9% | 0.003280572 |
| positive regulation of cell activation | 3 out of 39 genes, 7.7% | 5 out of 533 genes, 0.9% | 0.003280572 |
| muscle cell development | 3 out of 39 genes, 7.7% | 5 out of 533 genes, 0.9% | 0.003280572 |
| striated muscle cell development | 3 out of 39 genes, 7.7% | 5 out of 533 genes, 0.9% | 0.003280572 |
| regulation of blood pressure | 2 out of 39 genes, 5.1% | 2 out of 533 genes, 0.4% | 0.005226481 |
| gas transport | 2 out of 39 genes, 5.1% | 2 out of 533 genes, 0.4% | 0.005226481 |
| ruffle organization | 2 out of 39 genes, 5.1% | 2 out of 533 genes, 0.4% | 0.005226481 |
| sarcomere organization | 2 out of 39 genes, 5.1% | 2 out of 533 genes, 0.4% | 0.005226481 |
| single-organism cellular process | 31 out of 39 genes, 79.5% | 320 out of 533 genes, 60.0% | 0.006517685 |
| cellular component morphogenesis | 6 out of 39 genes, 15.4% | 25 out of 533 genes, 4.7% | 0.00652075 |
| regulation of biological quality | 11 out of 39 genes, 28.2% | 71 out of 533 genes, 13.3% | 0.008244725 |
| regulation of immune effector process | 3 out of 39 genes, 7.7% | 7 out of 533 genes, 1.3% | 0.01034789 |
| cellular component assembly involved in morphogenesis | 3 out of 39 genes, 7.7% | 7 out of 533 genes, 1.3% | 0.01034789 |
| striated muscle cell differentiation | 3 out of 39 genes, 7.7% | 7 out of 533 genes, 1.3% | 0.01034789 |
| regulation of anatomical structure size | 4 out of 39 genes, 10.3% | 13 out of 533 genes, 2.4% | 0.0108605 |
| cytoskeleton organization | 6 out of 39 genes, 15.4% | 28 out of 533 genes, 5.3% | 0.0117446 |
| cell development | 6 out of 39 genes, 15.4% | 29 out of 533 genes, 5.4% | 0.01400919 |
| response to stress | 11 out of 39 genes, 28.2% | 76 out of 533 genes, 14.3% | 0.01402556 |
| response to unfolded protein | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| muscle organ morphogenesis | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| cardiac muscle tissue development | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| regulation of defense response to virus | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| regulation of defense response to virus by virus | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| positive regulation of binding | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| response to calcium ion | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| cardiac muscle tissue morphogenesis | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| muscle tissue morphogenesis | 2 out of 39 genes, 5.1% | 3 out of 533 genes, 0.6% | 0.01495108 |
| regulation of leukocyte activation | 3 out of 39 genes, 7.7% | 8 out of 533 genes, 1.5% | 0.01572057 |
| regulation of cell activation | 3 out of 39 genes, 7.7% | 8 out of 533 genes, 1.5% | 0.01572057 |
| wound healing | 4 out of 39 genes, 10.3% | 15 out of 533 genes, 2.8% | 0.01861583 |
| response to wounding | 5 out of 39 genes, 12.8% | 23 out of 533 genes, 4.3% | 0.02043601 |
| organelle organization | 11 out of 39 genes, 28.2% | 80 out of 533 genes, 15.0% | 0.02059102 |
| regulation of actin filament polymerization | 3 out of 39 genes, 7.7% | 9 out of 533 genes, 1.7% | 0.02239292 |
| cell junction organization | 3 out of 39 genes, 7.7% | 9 out of 533 genes, 1.7% | 0.02239292 |
| muscle cell differentiation | 3 out of 39 genes, 7.7% | 9 out of 533 genes, 1.7% | 0.02239292 |
| cellular developmental process | 9 out of 39 genes, 23.1% | 61 out of 533 genes, 11.4% | 0.02429181 |
| protein complex subunit organization | 9 out of 39 genes, 23.1% | 61 out of 533 genes, 11.4% | 0.02429181 |
| macromolecular complex subunit organization | 11 out of 39 genes, 28.2% | 82 out of 533 genes, 15.4% | 0.02464233 |
| response to chemical stimulus | 10 out of 39 genes, 25.6% | 72 out of 533 genes, 13.5% | 0.02602529 |
| G2/M transition of mitotic cell cycle | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| heart morphogenesis | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| circulatory system process | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| heart process | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| blood circulation | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| actin-myosin filament sliding | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| response to topologically incorrect protein | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| innate immune response | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| positive regulation of lymphocyte activation | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| heart contraction | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| actin-mediated cell contraction | 2 out of 39 genes, 5.1% | 4 out of 533 genes, 0.8% | 0.02851965 |
| positive regulation of molecular function | 7 out of 39 genes, 17.9% | 43 out of 533 genes, 8.1% | 0.02902419 |
| DNA packaging | 3 out of 39 genes, 7.7% | 10 out of 533 genes, 1.9% | 0.03038228 |
| regulation of actin polymerization or depolymerization | 3 out of 39 genes, 7.7% | 10 out of 533 genes, 1.9% | 0.03038228 |
| regulation of actin filament length | 3 out of 39 genes, 7.7% | 10 out of 533 genes, 1.9% | 0.03038228 |
| regulation of protein polymerization | 3 out of 39 genes, 7.7% | 10 out of 533 genes, 1.9% | 0.03038228 |
| anatomical structure development | 10 out of 39 genes, 25.6% | 74 out of 533 genes, 13.9% | 0.03119824 |
| regulation of immune system process | 5 out of 39 genes, 12.8% | 26 out of 533 genes, 4.9% | 0.03388892 |
| regulation of hydrolase activity | 5 out of 39 genes, 12.8% | 26 out of 533 genes, 4.9% | 0.03388892 |
| cellular component movement | 6 out of 39 genes, 15.4% | 35 out of 533 genes, 6.6% | 0.03431829 |
| protein folding | 4 out of 39 genes, 10.3% | 18 out of 533 genes, 3.4% | 0.03552264 |
| single-organism developmental process | 9 out of 39 genes, 23.1% | 65 out of 533 genes, 12.2% | 0.03582098 |
| regulation of molecular function | 9 out of 39 genes, 23.1% | 66 out of 533 genes, 12.4% | 0.03922243 |
| cell projection organization | 5 out of 39 genes, 12.8% | 27 out of 533 genes, 5.1% | 0.03937405 |
| regulation of response to stress | 5 out of 39 genes, 12.8% | 27 out of 533 genes, 5.1% | 0.03937405 |
| cell activation | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| regulation of cytokine production | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| positive regulation of immune system process | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| extracellular matrix organization | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| regulation of actin cytoskeleton organization | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| regulation of actin filament-based process | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| extracellular structure organization | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| muscle structure development | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| DNA conformation change | 3 out of 39 genes, 7.7% | 11 out of 533 genes, 2.1% | 0.03968155 |
| cell differentiation | 8 out of 39 genes, 20.5% | 56 out of 533 genes, 10.5% | 0.04061433 |
| cellular component biogenesis | 11 out of 39 genes, 28.2% | 89 out of 533 genes, 16.7% | 0.0435952 |
| muscle system process | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| muscle contraction | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| actin filament organization | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| spindle organization | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| striated muscle tissue development | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| regulation of binding | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| positive regulation of cytoskeleton organization | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| muscle tissue development | 2 out of 39 genes, 5.1% | 5 out of 533 genes, 0.9% | 0.04534571 |
| locomotion | 5 out of 39 genes, 12.8% | 28 out of 533 genes, 5.3% | 0.04538045 |
| immune system process | 6 out of 39 genes, 15.4% | 38 out of 533 genes, 7.1% | 0.04942728 |
| blood coagulation | 3 out of 39 genes, 7.7% | 12 out of 533 genes, 2.3% | 0.05026349 |
| hemostasis | 3 out of 39 genes, 7.7% | 12 out of 533 genes, 2.3% | 0.05026349 |
| regulation of defense response | 3 out of 39 genes, 7.7% | 12 out of 533 genes, 2.3% | 0.05026349 |
| regulation of cellular component size | 3 out of 39 genes, 7.7% | 12 out of 533 genes, 2.3% | 0.05026349 |
| coagulation | 3 out of 39 genes, 7.7% | 12 out of 533 genes, 2.3% | 0.05026349 |
| response to stimulus | 18 out of 39 genes, 46.2% | 175 out of 533 genes, 32.8% | 0.05052775 |
| cell part morphogenesis | 4 out of 39 genes, 10.3% | 20 out of 533 genes, 3.8% | 0.05053563 |
| cell projection morphogenesis | 4 out of 39 genes, 10.3% | 20 out of 533 genes, 3.8% | 0.05053563 |
| anatomical structure morphogenesis | 6 out of 39 genes, 15.4% | 39 out of 533 genes, 7.3% | 0.05526616 |
| cell adhesion | 5 out of 39 genes, 12.8% | 30 out of 533 genes, 5.6% | 0.05898607 |
| biological adhesion | 5 out of 39 genes, 12.8% | 30 out of 533 genes, 5.6% | 0.05898607 |
| organ morphogenesis | 3 out of 39 genes, 7.7% | 13 out of 533 genes, 2.4% | 0.06208438 |
| muscle organ development | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| actin filament-based movement | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| negative regulation of actin filament depolymerization | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| negative regulation of actin filament polymerization | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| cell-substrate adhesion | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| cell cycle phase transition | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| mitotic cell cycle phase transition | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| cell-cell junction organization | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| actin filament capping | 2 out of 39 genes, 5.1% | 6 out of 533 genes, 1.1% | 0.0649044 |
| system development | 7 out of 39 genes, 17.9% | 51 out of 533 genes, 9.6% | 0.06673694 |
| cell morphogenesis | 4 out of 39 genes, 10.3% | 22 out of 533 genes, 4.1% | 0.0685774 |
| neuron differentiation | 4 out of 39 genes, 10.3% | 22 out of 533 genes, 4.1% | 0.0685774 |
| regulation of catalytic activity | 7 out of 39 genes, 17.9% | 52 out of 533 genes, 9.8% | 0.07293291 |
| cellular process involved in reproduction | 5 out of 39 genes, 12.8% | 32 out of 533 genes, 6.0% | 0.07473387 |
| cellular component assembly | 9 out of 39 genes, 23.1% | 74 out of 533 genes, 13.9% | 0.07480608 |
| axon guidance | 3 out of 39 genes, 7.7% | 14 out of 533 genes, 2.6% | 0.07508737 |
| regulation of body fluid levels | 3 out of 39 genes, 7.7% | 14 out of 533 genes, 2.6% | 0.07508737 |
| viral reproduction | 6 out of 39 genes, 15.4% | 42 out of 533 genes, 7.9% | 0.07526259 |
| regulation of phosphate metabolic process | 6 out of 39 genes, 15.4% | 42 out of 533 genes, 7.9% | 0.07526259 |
| multi-organism cellular process | 6 out of 39 genes, 15.4% | 42 out of 533 genes, 7.9% | 0.07526259 |
| regulation of phosphorus metabolic process | 6 out of 39 genes, 15.4% | 42 out of 533 genes, 7.9% | 0.07526259 |
| viral infectious cycle | 4 out of 39 genes, 10.3% | 23 out of 533 genes, 4.3% | 0.07871243 |
| multi-organism process | 7 out of 39 genes, 17.9% | 54 out of 533 genes, 10.1% | 0.0863524 |
| inflammatory response | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| response to metal ion | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| platelet activation | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| regulation of actin filament depolymerization | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| negative regulation of protein polymerization | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| cell junction assembly | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| negative regulation of protein complex disassembly | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| regulation of lymphocyte activation | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| protein polymerization | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| negative regulation of protein depolymerization | 2 out of 39 genes, 5.1% | 7 out of 533 genes, 1.3% | 0.086727 |
| M phase | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| cell migration | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| regulation of cell migration | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| positive regulation of kinase activity | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| regulation of locomotion | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| regulation of protein complex assembly | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| negative regulation of cellular component organization | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| positive regulation of hydrolase activity | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| positive regulation of transferase activity | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| regulation of cell motility | 3 out of 39 genes, 7.7% | 15 out of 533 genes, 2.8% | 0.08920525 |
| response to external stimulus | 4 out of 39 genes, 10.3% | 24 out of 533 genes, 4.5% | 0.08956784 |
| positive regulation of catalytic activity | 5 out of 39 genes, 12.8% | 34 out of 533 genes, 6.4% | 0.09260547 |
| defense response | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| axonogenesis | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| embryo development | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| neuron projection development | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| cell morphogenesis involved in neuron differentiation | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| neuron projection morphogenesis | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| cell motility | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| regulation of cellular component movement | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| regulation of cytoskeleton organization | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| localization of cell | 3 out of 39 genes, 7.7% | 16 out of 533 genes, 3.0% | 0.104363 |
| negative regulation of protein complex assembly | 2 out of 39 genes, 5.1% | 8 out of 533 genes, 1.5% | 0.1103958 |
| negative regulation of cytoskeleton organization | 2 out of 39 genes, 5.1% | 8 out of 533 genes, 1.5% | 0.1103958 |
| anatomical structure homeostasis | 2 out of 39 genes, 5.1% | 8 out of 533 genes, 1.5% | 0.1103958 |
| regulation of protein depolymerization | 2 out of 39 genes, 5.1% | 8 out of 533 genes, 1.5% | 0.1103958 |
| chemotaxis | 3 out of 39 genes, 7.7% | 17 out of 533 genes, 3.2% | 0.1204799 |
| tissue development | 3 out of 39 genes, 7.7% | 17 out of 533 genes, 3.2% | 0.1204799 |
| taxis | 3 out of 39 genes, 7.7% | 17 out of 533 genes, 3.2% | 0.1204799 |
| regulation of cellular component biogenesis | 3 out of 39 genes, 7.7% | 17 out of 533 genes, 3.2% | 0.1204799 |
| multicellular organismal process | 10 out of 39 genes, 25.6% | 93 out of 533 genes, 17.4% | 0.1209445 |
| nuclear-transcribed mRNA catabolic process | 4 out of 39 genes, 10.3% | 27 out of 533 genes, 5.1% | 0.1262094 |
| neurogenesis | 4 out of 39 genes, 10.3% | 27 out of 533 genes, 5.1% | 0.1262094 |
| generation of neurons | 4 out of 39 genes, 10.3% | 27 out of 533 genes, 5.1% | 0.1262094 |
| chromosome organization | 4 out of 39 genes, 10.3% | 27 out of 533 genes, 5.1% | 0.1262094 |
| cellular response to chemical stimulus | 6 out of 39 genes, 15.4% | 48 out of 533 genes, 9.0% | 0.1263927 |
| developmental process | 10 out of 39 genes, 25.6% | 94 out of 533 genes, 17.6% | 0.1279186 |
| multicellular organismal development | 8 out of 39 genes, 20.5% | 71 out of 533 genes, 13.3% | 0.1312298 |
| cellular process | 36 out of 39 genes, 92.3% | 453 out of 533 genes, 85.0% | 0.1333889 |
| nucleosome assembly | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| heart development | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| negative regulation of organelle organization | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| chromatin assembly | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| regulation of protein complex disassembly | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| cellular protein complex assembly | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| tissue morphogenesis | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| negative regulation of multicellular organismal process | 2 out of 39 genes, 5.1% | 9 out of 533 genes, 1.7% | 0.1355395 |
| regulation of multicellular organismal process | 6 out of 39 genes, 15.4% | 49 out of 533 genes, 9.2% | 0.1363039 |
| cell morphogenesis involved in differentiation | 3 out of 39 genes, 7.7% | 18 out of 533 genes, 3.4% | 0.1374713 |
| RNA catabolic process | 4 out of 39 genes, 10.3% | 28 out of 533 genes, 5.3% | 0.1396809 |
| mRNA catabolic process | 4 out of 39 genes, 10.3% | 28 out of 533 genes, 5.3% | 0.1396809 |
| cellular component disassembly | 4 out of 39 genes, 10.3% | 28 out of 533 genes, 5.3% | 0.1396809 |
| regulation of phosphorylation | 4 out of 39 genes, 10.3% | 28 out of 533 genes, 5.3% | 0.1396809 |
| positive regulation of protein phosphorylation | 3 out of 39 genes, 7.7% | 19 out of 533 genes, 3.6% | 0.1552505 |
| neuron development | 3 out of 39 genes, 7.7% | 19 out of 533 genes, 3.6% | 0.1552505 |
| nuclear division | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| chromatin assembly or disassembly | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| immune response | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| mitosis | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| response to biotic stimulus | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| positive regulation of organelle organization | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| nucleosome organization | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| regulation of multi-organism process | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| organelle fission | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| regulation of peptidase activity | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| regulation of endopeptidase activity | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| protein-DNA complex assembly | 2 out of 39 genes, 5.1% | 10 out of 533 genes, 1.9% | 0.1618288 |
| cellular macromolecular complex assembly | 4 out of 39 genes, 10.3% | 30 out of 533 genes, 5.6% | 0.1682983 |
| homeostatic process | 4 out of 39 genes, 10.3% | 30 out of 533 genes, 5.6% | 0.1682983 |
| system process | 3 out of 39 genes, 7.7% | 20 out of 533 genes, 3.8% | 0.1737296 |
| cellular membrane organization | 3 out of 39 genes, 7.7% | 20 out of 533 genes, 3.8% | 0.1737296 |
| positive regulation of phosphorylation | 3 out of 39 genes, 7.7% | 20 out of 533 genes, 3.8% | 0.1737296 |
| anatomical structure formation involved in morphogenesis | 3 out of 39 genes, 7.7% | 20 out of 533 genes, 3.8% | 0.1737296 |
| membrane organization | 3 out of 39 genes, 7.7% | 20 out of 533 genes, 3.8% | 0.1737296 |
| single-multicellular organism process | 9 out of 39 genes, 23.1% | 88 out of 533 genes, 16.5% | 0.1758199 |
| response to organic substance | 6 out of 39 genes, 15.4% | 53 out of 533 genes, 9.9% | 0.1795629 |
| organ development | 4 out of 39 genes, 10.3% | 31 out of 533 genes, 5.8% | 0.1833658 |
| M phase of mitotic cell cycle | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| microtubule cytoskeleton organization | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| rRNA processing | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| rRNA metabolic process | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| sexual reproduction | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| positive regulation of multicellular organismal process | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| protein-DNA complex subunit organization | 2 out of 39 genes, 5.1% | 11 out of 533 genes, 2.1% | 0.1889726 |
| translational termination | 3 out of 39 genes, 7.7% | 21 out of 533 genes, 3.9% | 0.1928211 |
| response to abiotic stimulus | 3 out of 39 genes, 7.7% | 21 out of 533 genes, 3.9% | 0.1928211 |
| viral genome expression | 3 out of 39 genes, 7.7% | 21 out of 533 genes, 3.9% | 0.1928211 |
| viral transcription | 3 out of 39 genes, 7.7% | 21 out of 533 genes, 3.9% | 0.1928211 |
| reproduction | 6 out of 39 genes, 15.4% | 55 out of 533 genes, 10.3% | 0.2031698 |
| chromatin organization | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| positive regulation of phosphorus metabolic process | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| regulation of organelle organization | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| protein complex disassembly | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| regulation of kinase activity | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| cellular protein complex disassembly | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| positive regulation of phosphate metabolic process | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| regulation of transferase activity | 3 out of 39 genes, 7.7% | 22 out of 533 genes, 4.1% | 0.2124385 |
| response to inorganic substance | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| positive regulation of cell death | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| cellular homeostasis | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| neurotrophin signaling pathway | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| positive regulation of apoptotic process | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| positive regulation of programmed cell death | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| neurotrophin TRK receptor signaling pathway | 2 out of 39 genes, 5.1% | 12 out of 533 genes, 2.3% | 0.2167145 |
| DNA metabolic process | 4 out of 39 genes, 10.3% | 34 out of 533 genes, 6.4% | 0.2311069 |
| cell cycle phase | 3 out of 39 genes, 7.7% | 23 out of 533 genes, 4.3% | 0.2324974 |
| macromolecular complex disassembly | 3 out of 39 genes, 7.7% | 23 out of 533 genes, 4.3% | 0.2324974 |
| single-organism transport | 9 out of 39 genes, 23.1% | 94 out of 533 genes, 17.6% | 0.2333225 |
| cellular nitrogen compound catabolic process | 7 out of 39 genes, 17.9% | 70 out of 533 genes, 13.1% | 0.2398638 |
| heterocycle catabolic process | 7 out of 39 genes, 17.9% | 70 out of 533 genes, 13.1% | 0.2398638 |
| organic cyclic compound catabolic process | 7 out of 39 genes, 17.9% | 70 out of 533 genes, 13.1% | 0.2398638 |
| single organism reproductive process | 2 out of 39 genes, 5.1% | 13 out of 533 genes, 2.4% | 0.244829 |
| positive regulation of protein kinase activity | 2 out of 39 genes, 5.1% | 13 out of 533 genes, 2.4% | 0.244829 |
| mitotic cell cycle | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| cotranslational protein targeting to membrane | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| SRP-dependent cotranslational protein targeting to membrane | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| negative regulation of signal transduction | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| protein targeting to ER | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| protein localization to endoplasmic reticulum | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| establishment of protein localization to endoplasmic reticulum | 3 out of 39 genes, 7.7% | 24 out of 533 genes, 4.5% | 0.2529159 |
| cellular macromolecule catabolic process | 6 out of 39 genes, 15.4% | 59 out of 533 genes, 11.1% | 0.2536919 |
| nervous system development | 4 out of 39 genes, 10.3% | 36 out of 533 genes, 6.8% | 0.2646228 |
| protein localization to organelle | 4 out of 39 genes, 10.3% | 36 out of 533 genes, 6.8% | 0.2646228 |
| response to organic cyclic compound | 2 out of 39 genes, 5.1% | 14 out of 533 genes, 2.6% | 0.2731193 |
| negative regulation of developmental process | 2 out of 39 genes, 5.1% | 14 out of 533 genes, 2.6% | 0.2731193 |
| cell division | 2 out of 39 genes, 5.1% | 14 out of 533 genes, 2.6% | 0.2731193 |
| cardiovascular system development | 2 out of 39 genes, 5.1% | 14 out of 533 genes, 2.6% | 0.2731193 |
| circulatory system development | 2 out of 39 genes, 5.1% | 14 out of 533 genes, 2.6% | 0.2731193 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3 out of 39 genes, 7.7% | 25 out of 533 genes, 4.7% | 0.2736152 |
| regulation of protein phosphorylation | 3 out of 39 genes, 7.7% | 25 out of 533 genes, 4.7% | 0.2736152 |
| viral reproductive process | 4 out of 39 genes, 10.3% | 37 out of 533 genes, 6.9% | 0.2817589 |
| protein targeting to membrane | 3 out of 39 genes, 7.7% | 26 out of 533 genes, 4.9% | 0.29452 |
| negative regulation of cell communication | 3 out of 39 genes, 7.7% | 26 out of 533 genes, 4.9% | 0.29452 |
| negative regulation of signaling | 3 out of 39 genes, 7.7% | 26 out of 533 genes, 4.9% | 0.29452 |
| reproductive process | 5 out of 39 genes, 12.8% | 50 out of 533 genes, 9.4% | 0.2978376 |
| macromolecular complex assembly | 5 out of 39 genes, 12.8% | 50 out of 533 genes, 9.4% | 0.2978376 |
| multi-organism reproductive process | 4 out of 39 genes, 10.3% | 38 out of 533 genes, 7.1% | 0.2990912 |
| ncRNA processing | 2 out of 39 genes, 5.1% | 15 out of 533 genes, 2.8% | 0.3014138 |
| macromolecule catabolic process | 6 out of 39 genes, 15.4% | 63 out of 533 genes, 11.8% | 0.3076445 |
| intracellular protein transport | 5 out of 39 genes, 12.8% | 51 out of 533 genes, 9.6% | 0.3131204 |
| establishment of protein localization to organelle | 3 out of 39 genes, 7.7% | 27 out of 533 genes, 5.1% | 0.3155589 |
| protein targeting | 4 out of 39 genes, 10.3% | 39 out of 533 genes, 7.3% | 0.3165786 |
| cellular response to organic substance | 4 out of 39 genes, 10.3% | 39 out of 533 genes, 7.3% | 0.3165786 |
| chromatin modification | 2 out of 39 genes, 5.1% | 16 out of 533 genes, 3.0% | 0.3295639 |
| response to growth factor stimulus | 2 out of 39 genes, 5.1% | 16 out of 533 genes, 3.0% | 0.3295639 |
| cellular response to growth factor stimulus | 2 out of 39 genes, 5.1% | 16 out of 533 genes, 3.0% | 0.3295639 |
| translational initiation | 3 out of 39 genes, 7.7% | 28 out of 533 genes, 5.3% | 0.3366642 |
| positive regulation of protein modification process | 3 out of 39 genes, 7.7% | 28 out of 533 genes, 5.3% | 0.3366642 |
| negative regulation of response to stimulus | 3 out of 39 genes, 7.7% | 28 out of 533 genes, 5.3% | 0.3366642 |
| cellular catabolic process | 9 out of 39 genes, 23.1% | 104 out of 533 genes, 19.5% | 0.3428981 |
| nucleobase-containing compound catabolic process | 6 out of 39 genes, 15.4% | 66 out of 533 genes, 12.4% | 0.3496124 |
| apoptotic process | 2 out of 39 genes, 5.1% | 17 out of 533 genes, 3.2% | 0.3574418 |
| programmed cell death | 2 out of 39 genes, 5.1% | 17 out of 533 genes, 3.2% | 0.3574418 |
| negative regulation of apoptotic process | 2 out of 39 genes, 5.1% | 17 out of 533 genes, 3.2% | 0.3574418 |
| protein complex assembly | 3 out of 39 genes, 7.7% | 29 out of 533 genes, 5.4% | 0.3577728 |
| biological regulation | 22 out of 39 genes, 56.4% | 279 out of 533 genes, 52.3% | 0.3598399 |
| transport | 11 out of 39 genes, 28.2% | 132 out of 533 genes, 24.8% | 0.3636828 |
| aromatic compound catabolic process | 6 out of 39 genes, 15.4% | 67 out of 533 genes, 12.6% | 0.3637831 |
| establishment of localization | 11 out of 39 genes, 28.2% | 133 out of 533 genes, 25.0% | 0.3744899 |
| cellular response to stimulus | 11 out of 39 genes, 28.2% | 133 out of 533 genes, 25.0% | 0.3744899 |
| negative regulation of biological process | 9 out of 39 genes, 23.1% | 107 out of 533 genes, 20.1% | 0.3779398 |
| protein complex biogenesis | 3 out of 39 genes, 7.7% | 30 out of 533 genes, 5.6% | 0.3788255 |
| cell death | 2 out of 39 genes, 5.1% | 18 out of 533 genes, 3.4% | 0.3849381 |
| death | 2 out of 39 genes, 5.1% | 18 out of 533 genes, 3.4% | 0.3849381 |
| ribosome biogenesis | 2 out of 39 genes, 5.1% | 18 out of 533 genes, 3.4% | 0.3849381 |
| negative regulation of programmed cell death | 2 out of 39 genes, 5.1% | 18 out of 533 genes, 3.4% | 0.3849381 |
| positive regulation of cellular component organization | 2 out of 39 genes, 5.1% | 18 out of 533 genes, 3.4% | 0.3849381 |
| negative regulation of cell death | 2 out of 39 genes, 5.1% | 18 out of 533 genes, 3.4% | 0.3849381 |
| localization | 12 out of 39 genes, 30.8% | 148 out of 533 genes, 27.8% | 0.3932393 |
| cellular response to oxygen-containing compound | 2 out of 39 genes, 5.1% | 19 out of 533 genes, 3.6% | 0.4119601 |
| positive regulation of cellular protein metabolic process | 3 out of 39 genes, 7.7% | 32 out of 533 genes, 6.0% | 0.4205486 |
| regulation of response to stimulus | 6 out of 39 genes, 15.4% | 71 out of 533 genes, 13.3% | 0.420861 |
| organic substance catabolic process | 9 out of 39 genes, 23.1% | 111 out of 533 genes, 20.8% | 0.4253846 |
| transmembrane receptor protein tyrosine kinase signaling pathway | 2 out of 39 genes, 5.1% | 20 out of 533 genes, 3.8% | 0.4384302 |
| regulation of protein kinase activity | 2 out of 39 genes, 5.1% | 20 out of 533 genes, 3.8% | 0.4384302 |
| cell cycle process | 3 out of 39 genes, 7.7% | 33 out of 533 genes, 6.2% | 0.4411222 |
| signal transduction | 8 out of 39 genes, 20.5% | 99 out of 533 genes, 18.6% | 0.4413097 |
| negative regulation of cellular process | 8 out of 39 genes, 20.5% | 99 out of 533 genes, 18.6% | 0.4413097 |
| cellular protein localization | 5 out of 39 genes, 12.8% | 60 out of 533 genes, 11.3% | 0.4534621 |
| cellular macromolecule localization | 5 out of 39 genes, 12.8% | 60 out of 533 genes, 11.3% | 0.4534621 |
| nucleic acid metabolic process | 9 out of 39 genes, 23.1% | 114 out of 533 genes, 21.4% | 0.4611382 |
| microtubule-based process | 2 out of 39 genes, 5.1% | 21 out of 533 genes, 3.9% | 0.4642838 |
| enzyme linked receptor protein signaling pathway | 2 out of 39 genes, 5.1% | 21 out of 533 genes, 3.9% | 0.4642838 |
| ncRNA metabolic process | 2 out of 39 genes, 5.1% | 21 out of 533 genes, 3.9% | 0.4642838 |
| regulation of protein metabolic process | 5 out of 39 genes, 12.8% | 61 out of 533 genes, 11.4% | 0.4689216 |
| catabolic process | 9 out of 39 genes, 23.1% | 115 out of 533 genes, 21.6% | 0.4730332 |
| regulation of cell death | 3 out of 39 genes, 7.7% | 35 out of 533 genes, 6.6% | 0.4814827 |
| vesicle-mediated transport | 3 out of 39 genes, 7.7% | 35 out of 533 genes, 6.6% | 0.4814827 |
| regulation of protein modification process | 3 out of 39 genes, 7.7% | 35 out of 533 genes, 6.6% | 0.4814827 |
| regulation of apoptotic process | 3 out of 39 genes, 7.7% | 35 out of 533 genes, 6.6% | 0.4814827 |
| regulation of programmed cell death | 3 out of 39 genes, 7.7% | 35 out of 533 genes, 6.6% | 0.4814827 |
| signaling | 8 out of 39 genes, 20.5% | 103 out of 533 genes, 19.3% | 0.4911749 |
| single organism signaling | 8 out of 39 genes, 20.5% | 103 out of 533 genes, 19.3% | 0.4911749 |
| positive regulation of protein metabolic process | 3 out of 39 genes, 7.7% | 36 out of 533 genes, 6.8% | 0.5011972 |
| cytoplasmic transport | 4 out of 39 genes, 10.3% | 50 out of 533 genes, 9.4% | 0.5087405 |
| cellular localization | 7 out of 39 genes, 17.9% | 91 out of 533 genes, 17.1% | 0.5110361 |
| regulation of multicellular organismal development | 2 out of 39 genes, 5.1% | 23 out of 533 genes, 4.3% | 0.5139417 |
| intracellular transport | 6 out of 39 genes, 15.4% | 78 out of 533 genes, 14.6% | 0.5195358 |
| RNA biosynthetic process | 3 out of 39 genes, 7.7% | 37 out of 533 genes, 6.9% | 0.5205594 |
| positive regulation of response to stimulus | 3 out of 39 genes, 7.7% | 37 out of 533 genes, 6.9% | 0.5205594 |
| regulation of developmental process | 3 out of 39 genes, 7.7% | 37 out of 533 genes, 6.9% | 0.5205594 |
| translation | 4 out of 39 genes, 10.3% | 51 out of 533 genes, 9.6% | 0.525389 |
| regulation of cellular protein metabolic process | 4 out of 39 genes, 10.3% | 51 out of 533 genes, 9.6% | 0.525389 |
| positive regulation of cellular process | 8 out of 39 genes, 20.5% | 106 out of 533 genes, 19.9% | 0.528037 |
| cell communication | 8 out of 39 genes, 20.5% | 107 out of 533 genes, 20.1% | 0.5401661 |
| regulation of localization | 4 out of 39 genes, 10.3% | 52 out of 533 genes, 9.8% | 0.5417936 |
| translational elongation | 2 out of 39 genes, 5.1% | 25 out of 533 genes, 4.7% | 0.5606327 |
| ribonucleoprotein complex biogenesis | 2 out of 39 genes, 5.1% | 25 out of 533 genes, 4.7% | 0.5606327 |
| regulation of cell cycle | 2 out of 39 genes, 5.1% | 25 out of 533 genes, 4.7% | 0.5606327 |
| establishment of localization in cell | 6 out of 39 genes, 15.4% | 82 out of 533 genes, 15.4% | 0.5735184 |
| cell cycle | 3 out of 39 genes, 7.7% | 40 out of 533 genes, 7.5% | 0.5762801 |
| organonitrogen compound catabolic process | 3 out of 39 genes, 7.7% | 40 out of 533 genes, 7.5% | 0.5762801 |
| GTP catabolic process | 2 out of 39 genes, 5.1% | 27 out of 533 genes, 5.1% | 0.6041888 |
| guanosine-containing compound catabolic process | 2 out of 39 genes, 5.1% | 27 out of 533 genes, 5.1% | 0.6041888 |
| response to oxygen-containing compound | 2 out of 39 genes, 5.1% | 27 out of 533 genes, 5.1% | 0.6041888 |
| proteolysis | 3 out of 39 genes, 7.7% | 42 out of 533 genes, 7.9% | 0.6112607 |
| response to endogenous stimulus | 2 out of 39 genes, 5.1% | 28 out of 533 genes, 5.3% | 0.6247676 |
| protein transport | 5 out of 39 genes, 12.8% | 72 out of 533 genes, 13.5% | 0.6282575 |
| regulation of signal transduction | 4 out of 39 genes, 10.3% | 58 out of 533 genes, 10.9% | 0.6341834 |
| establishment of protein localization | 5 out of 39 genes, 12.8% | 73 out of 533 genes, 13.7% | 0.6414102 |
| positive regulation of biological process | 8 out of 39 genes, 20.5% | 116 out of 533 genes, 21.8% | 0.6440169 |
| proteolysis involved in cellular protein catabolic process | 2 out of 39 genes, 5.1% | 29 out of 533 genes, 5.4% | 0.644545 |
| macromolecule metabolic process | 16 out of 39 genes, 41.0% | 229 out of 533 genes, 43.0% | 0.661202 |
| cellular protein catabolic process | 2 out of 39 genes, 5.1% | 30 out of 533 genes, 5.6% | 0.663525 |
| GTP metabolic process | 2 out of 39 genes, 5.1% | 30 out of 533 genes, 5.6% | 0.663525 |
| guanosine-containing compound metabolic process | 2 out of 39 genes, 5.1% | 30 out of 533 genes, 5.6% | 0.663525 |
| positive regulation of metabolic process | 5 out of 39 genes, 12.8% | 75 out of 533 genes, 14.1% | 0.6669109 |
| cellular macromolecule metabolic process | 15 out of 39 genes, 38.5% | 216 out of 533 genes, 40.5% | 0.667818 |
| regulation of cellular component organization | 3 out of 39 genes, 7.7% | 46 out of 533 genes, 8.6% | 0.6755756 |
| positive regulation of signal transduction | 2 out of 39 genes, 5.1% | 32 out of 533 genes, 6.0% | 0.6991262 |
| positive regulation of cell communication | 2 out of 39 genes, 5.1% | 32 out of 533 genes, 6.0% | 0.6991262 |
| positive regulation of signaling | 2 out of 39 genes, 5.1% | 32 out of 533 genes, 6.0% | 0.6991262 |
| protein catabolic process | 2 out of 39 genes, 5.1% | 32 out of 533 genes, 6.0% | 0.6991262 |
| nucleobase-containing compound metabolic process | 11 out of 39 genes, 28.2% | 165 out of 533 genes, 31.0% | 0.7093762 |
| purine nucleoside catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| nucleoside triphosphate catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| purine nucleoside triphosphate catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| nucleoside catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| ribonucleoside triphosphate catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| purine ribonucleoside triphosphate catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| ribonucleoside catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| purine ribonucleoside catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| glycosyl compound catabolic process | 2 out of 39 genes, 5.1% | 33 out of 533 genes, 6.2% | 0.7157716 |
| regulation of metabolic process | 11 out of 39 genes, 28.2% | 166 out of 533 genes, 31.1% | 0.718247 |
| RNA processing | 3 out of 39 genes, 7.7% | 49 out of 533 genes, 9.2% | 0.718706 |
| purine nucleotide catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| purine ribonucleotide catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| nucleotide catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| ribonucleotide catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| organophosphate catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| purine-containing compound catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| nucleoside phosphate catabolic process | 2 out of 39 genes, 5.1% | 34 out of 533 genes, 6.4% | 0.731667 |
| regulation of cell communication | 4 out of 39 genes, 10.3% | 66 out of 533 genes, 12.4% | 0.7384413 |
| mRNA metabolic process | 4 out of 39 genes, 10.3% | 66 out of 533 genes, 12.4% | 0.7384413 |
| cellular aromatic compound metabolic process | 11 out of 39 genes, 28.2% | 169 out of 533 genes, 31.7% | 0.74394 |
| carbohydrate derivative catabolic process | 2 out of 39 genes, 5.1% | 35 out of 533 genes, 6.6% | 0.7468297 |
| regulation of signaling | 4 out of 39 genes, 10.3% | 67 out of 533 genes, 12.6% | 0.7498468 |
| heterocycle metabolic process | 11 out of 39 genes, 28.2% | 170 out of 533 genes, 31.9% | 0.7521899 |
| regulation of transport | 2 out of 39 genes, 5.1% | 36 out of 533 genes, 6.8% | 0.7612786 |
| cellular protein metabolic process | 9 out of 39 genes, 23.1% | 143 out of 533 genes, 26.8% | 0.7656892 |
| protein localization | 5 out of 39 genes, 12.8% | 84 out of 533 genes, 15.8% | 0.7674848 |
| organic substance transport | 5 out of 39 genes, 12.8% | 84 out of 533 genes, 15.8% | 0.7674848 |
| protein metabolic process | 10 out of 39 genes, 25.6% | 158 out of 533 genes, 29.6% | 0.7704981 |
| positive regulation of cellular metabolic process | 4 out of 39 genes, 10.3% | 69 out of 533 genes, 12.9% | 0.7715736 |
| positive regulation of macromolecule metabolic process | 4 out of 39 genes, 10.3% | 70 out of 533 genes, 13.1% | 0.7819001 |
| cellular nitrogen compound metabolic process | 11 out of 39 genes, 28.2% | 174 out of 533 genes, 32.6% | 0.7835697 |
| nucleobase-containing compound biosynthetic process | 3 out of 39 genes, 7.7% | 55 out of 533 genes, 10.3% | 0.7920044 |
| nucleobase-containing small molecule metabolic process | 3 out of 39 genes, 7.7% | 55 out of 533 genes, 10.3% | 0.7920044 |
| organic cyclic compound metabolic process | 11 out of 39 genes, 28.2% | 176 out of 533 genes, 33.0% | 0.7982711 |
| purine nucleoside triphosphate metabolic process | 2 out of 39 genes, 5.1% | 39 out of 533 genes, 7.3% | 0.800549 |
| purine ribonucleoside triphosphate metabolic process | 2 out of 39 genes, 5.1% | 39 out of 533 genes, 7.3% | 0.800549 |
| cell surface receptor signaling pathway | 3 out of 39 genes, 7.7% | 56 out of 533 genes, 10.5% | 0.8026106 |
| RNA metabolic process | 5 out of 39 genes, 12.8% | 88 out of 533 genes, 16.5% | 0.8045426 |
| regulation of cellular metabolic process | 9 out of 39 genes, 23.1% | 148 out of 533 genes, 27.8% | 0.8047483 |
| ribonucleoside triphosphate metabolic process | 2 out of 39 genes, 5.1% | 40 out of 533 genes, 7.5% | 0.8123526 |
| cellular response to stress | 2 out of 39 genes, 5.1% | 40 out of 533 genes, 7.5% | 0.8123526 |
| purine nucleoside metabolic process | 2 out of 39 genes, 5.1% | 40 out of 533 genes, 7.5% | 0.8123526 |
| purine ribonucleoside metabolic process | 2 out of 39 genes, 5.1% | 40 out of 533 genes, 7.5% | 0.8123526 |
| regulation of primary metabolic process | 9 out of 39 genes, 23.1% | 150 out of 533 genes, 28.1% | 0.8190588 |
| aromatic compound biosynthetic process | 3 out of 39 genes, 7.7% | 58 out of 533 genes, 10.9% | 0.822521 |
| nucleoside triphosphate metabolic process | 2 out of 39 genes, 5.1% | 41 out of 533 genes, 7.7% | 0.8235503 |
| heterocycle biosynthetic process | 3 out of 39 genes, 7.7% | 59 out of 533 genes, 11.1% | 0.8318459 |
| cellular nitrogen compound biosynthetic process | 3 out of 39 genes, 7.7% | 59 out of 533 genes, 11.1% | 0.8318459 |
| nitrogen compound metabolic process | 11 out of 39 genes, 28.2% | 181 out of 533 genes, 34.0% | 0.8321104 |
| gene expression | 6 out of 39 genes, 15.4% | 107 out of 533 genes, 20.1% | 0.8329261 |
| ribonucleoside metabolic process | 2 out of 39 genes, 5.1% | 42 out of 533 genes, 7.9% | 0.8341648 |
| regulation of biological process | 17 out of 39 genes, 43.6% | 267 out of 533 genes, 50.1% | 0.8437791 |
| purine nucleotide metabolic process | 2 out of 39 genes, 5.1% | 43 out of 533 genes, 8.1% | 0.8442188 |
| nucleoside metabolic process | 2 out of 39 genes, 5.1% | 43 out of 533 genes, 8.1% | 0.8442188 |
| purine ribonucleotide metabolic process | 2 out of 39 genes, 5.1% | 43 out of 533 genes, 8.1% | 0.8442188 |
| purine-containing compound metabolic process | 2 out of 39 genes, 5.1% | 43 out of 533 genes, 8.1% | 0.8442188 |
| glycosyl compound metabolic process | 2 out of 39 genes, 5.1% | 43 out of 533 genes, 8.1% | 0.8442188 |
| macromolecule localization | 5 out of 39 genes, 12.8% | 94 out of 533 genes, 17.6% | 0.8516307 |
| ribonucleotide metabolic process | 2 out of 39 genes, 5.1% | 44 out of 533 genes, 8.3% | 0.8537349 |
| ribose phosphate metabolic process | 2 out of 39 genes, 5.1% | 44 out of 533 genes, 8.3% | 0.8537349 |
| organic cyclic compound biosynthetic process | 3 out of 39 genes, 7.7% | 62 out of 533 genes, 11.6% | 0.8574302 |
| macromolecule biosynthetic process | 4 out of 39 genes, 10.3% | 79 out of 533 genes, 14.8% | 0.8595664 |
| cellular macromolecule biosynthetic process | 4 out of 39 genes, 10.3% | 79 out of 533 genes, 14.8% | 0.8595664 |
| regulation of cellular process | 15 out of 39 genes, 38.5% | 249 out of 533 genes, 46.7% | 0.893045 |
| primary metabolic process | 19 out of 39 genes, 48.7% | 304 out of 533 genes, 57.0% | 0.8953402 |
| intracellular signal transduction | 2 out of 39 genes, 5.1% | 50 out of 533 genes, 9.4% | 0.9007657 |
| organonitrogen compound metabolic process | 3 out of 39 genes, 7.7% | 69 out of 533 genes, 12.9% | 0.9046714 |
| nucleoside phosphate metabolic process | 2 out of 39 genes, 5.1% | 51 out of 533 genes, 9.6% | 0.9071223 |
| nucleotide metabolic process | 2 out of 39 genes, 5.1% | 51 out of 533 genes, 9.6% | 0.9071223 |
| carbohydrate derivative metabolic process | 2 out of 39 genes, 5.1% | 51 out of 533 genes, 9.6% | 0.9071223 |
| organophosphate metabolic process | 2 out of 39 genes, 5.1% | 53 out of 533 genes, 9.9% | 0.9187423 |
| cellular metabolic process | 18 out of 39 genes, 46.2% | 297 out of 533 genes, 55.7% | 0.9213412 |
| organic substance metabolic process | 19 out of 39 genes, 48.7% | 311 out of 533 genes, 58.3% | 0.9237023 |
| small molecule metabolic process | 4 out of 39 genes, 10.3% | 95 out of 533 genes, 17.8% | 0.9417637 |
| regulation of macromolecule metabolic process | 7 out of 39 genes, 17.9% | 146 out of 533 genes, 27.4% | 0.9458119 |
| cellular biosynthetic process | 5 out of 39 genes, 12.8% | 114 out of 533 genes, 21.4% | 0.9476761 |
| metabolic process | 19 out of 39 genes, 48.7% | 321 out of 533 genes, 60.2% | 0.9537931 |
| organic substance biosynthetic process | 5 out of 39 genes, 12.8% | 118 out of 533 genes, 22.1% | 0.9584268 |
| biosynthetic process | 5 out of 39 genes, 12.8% | 120 out of 533 genes, 22.5% | 0.9630387 |
| regulation of nucleobase-containing compound metabolic process | 4 out of 39 genes, 10.3% | 111 out of 533 genes, 20.8% | 0.9784186 |
| single-organism metabolic process | 4 out of 39 genes, 10.3% | 113 out of 533 genes, 21.2% | 0.9810776 |
| phosphorus metabolic process | 2 out of 39 genes, 5.1% | 75 out of 533 genes, 14.1% | 0.983088 |
| phosphate-containing compound metabolic process | 2 out of 39 genes, 5.1% | 75 out of 533 genes, 14.1% | 0.983088 |
| regulation of nitrogen compound metabolic process | 4 out of 39 genes, 10.3% | 115 out of 533 genes, 21.6% | 0.9834354 |
| regulation of gene expression | 4 out of 39 genes, 10.3% | 116 out of 533 genes, 21.8% | 0.9845109 |
| regulation of cellular macromolecule biosynthetic process | 3 out of 39 genes, 7.7% | 99 out of 533 genes, 18.6% | 0.9866331 |
| regulation of macromolecule biosynthetic process | 3 out of 39 genes, 7.7% | 103 out of 533 genes, 19.3% | 0.9899809 |
| regulation of transcription, DNA-dependent | 2 out of 39 genes, 5.1% | 82 out of 533 genes, 15.4% | 0.990085 |
| regulation of cellular biosynthetic process | 3 out of 39 genes, 7.7% | 105 out of 533 genes, 19.7% | 0.9913447 |
| regulation of RNA biosynthetic process | 2 out of 39 genes, 5.1% | 84 out of 533 genes, 15.8% | 0.9915122 |
| regulation of biosynthetic process | 3 out of 39 genes, 7.7% | 108 out of 533 genes, 20.3% | 0.9930691 |
| regulation of RNA metabolic process | 2 out of 39 genes, 5.1% | 92 out of 533 genes, 17.3% | 0.9954977 |
| Gene Ontology term | Genes annotated to the term |
|---|
| cellular component organization or biogenesis | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000005743, ENSAPLP00000003689, ENSAPLP00000015662, ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000004998, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000010726 |
| cellular component organization | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000005743, ENSAPLP00000003689, ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000004998, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000010726 |
| single-organism process | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000011711, ENSAPLP00000001729, ENSAPLP00000014548, ENSAPLP00000003219, ENSAPLP00000010726, ENSAPLP00000013787, ENSAPLP00000016219, ENSAPLP00000003689, ENSAPLP00000005743, ENSAPLP00000015662, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000007755, ENSAPLP00000004998, ENSAPLP00000002381, ENSAPLP00000011000, ENSAPLP00000002711, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000011900, ENSAPLP00000000463 |
| regulation of response to biotic stimulus | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| myofibril assembly | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based process | ENSAPLP00000009880, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000014548, ENSAPLP00000002381, ENSAPLP00000004998 |
| actin cytoskeleton organization | ENSAPLP00000009880, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000014548, ENSAPLP00000002381 |
| positive regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| muscle cell development | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| gas transport | ENSAPLP00000011711, ENSAPLP00000015662 |
| ruffle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| sarcomere organization | ENSAPLP00000009880, ENSAPLP00000003219 |
| single-organism cellular process | ENSAPLP00000013787, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000016219, ENSAPLP00000008674, ENSAPLP00000005743, ENSAPLP00000003689, ENSAPLP00000015662, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000004998, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000000463 |
| cellular component morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381, ENSAPLP00000004998 |
| regulation of biological quality | ENSAPLP00000003867, ENSAPLP00000016219, ENSAPLP00000001720, ENSAPLP00000015662, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000004998, ENSAPLP00000002381 |
| regulation of immune effector process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell differentiation | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of anatomical structure size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381, ENSAPLP00000004998 |
| cytoskeleton organization | ENSAPLP00000009880, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000014548, ENSAPLP00000002381 |
| cell development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000002381 |
| response to stress | ENSAPLP00000003867, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007755 |
| response to unfolded protein | ENSAPLP00000004358, ENSAPLP00000002711 |
| muscle organ morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of defense response to virus | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of defense response to virus by virus | ENSAPLP00000006303, ENSAPLP00000003050 |
| positive regulation of binding | ENSAPLP00000013416, ENSAPLP00000005743 |
| response to calcium ion | ENSAPLP00000009880, ENSAPLP00000003867 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| wound healing | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000003867 |
| response to wounding | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000005038 |
| organelle organization | ENSAPLP00000011000, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000014548, ENSAPLP00000009880, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| regulation of actin filament polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| cell junction organization | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000008674 |
| muscle cell differentiation | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular developmental process | ENSAPLP00000013416, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000004998, ENSAPLP00000002381 |
| protein complex subunit organization | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002381 |
| macromolecular complex subunit organization | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000014548, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002381 |
| response to chemical stimulus | ENSAPLP00000008717, ENSAPLP00000003867, ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000014548, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219 |
| G2/M transition of mitotic cell cycle | ENSAPLP00000000447, ENSAPLP00000007755 |
| heart morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003219, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003219, ENSAPLP00000002381 |
| response to topologically incorrect protein | ENSAPLP00000004358, ENSAPLP00000002711 |
| innate immune response | ENSAPLP00000007755, ENSAPLP00000005038 |
| positive regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| heart contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| positive regulation of molecular function | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000005743 |
| DNA packaging | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| regulation of actin filament length | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| regulation of protein polymerization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| anatomical structure development | ENSAPLP00000013416, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000015078, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000004998, ENSAPLP00000002381 |
| regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000014548 |
| cellular component movement | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000008674, ENSAPLP00000007755, ENSAPLP00000002381 |
| protein folding | ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000014548, ENSAPLP00000004942 |
| single-organism developmental process | ENSAPLP00000013416, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000015078, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998, ENSAPLP00000002381 |
| regulation of molecular function | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000014548, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447 |
| cell projection organization | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| regulation of response to stress | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000005743 |
| cell activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003867 |
| regulation of cytokine production | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| extracellular matrix organization | ENSAPLP00000013972, ENSAPLP00000005743, ENSAPLP00000003689 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| regulation of actin filament-based process | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| extracellular structure organization | ENSAPLP00000013972, ENSAPLP00000005743, ENSAPLP00000003689 |
| muscle structure development | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| DNA conformation change | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729 |
| cell differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000015662, ENSAPLP00000002381 |
| cellular component biogenesis | ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000014548, ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000003050, ENSAPLP00000007755 |
| muscle system process | ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament organization | ENSAPLP00000014548, ENSAPLP00000002381 |
| spindle organization | ENSAPLP00000013416, ENSAPLP00000007755 |
| striated muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of binding | ENSAPLP00000013416, ENSAPLP00000005743 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| locomotion | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000008674, ENSAPLP00000007755 |
| immune system process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000015662 |
| blood coagulation | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003867 |
| hemostasis | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003867 |
| regulation of defense response | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of cellular component size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| coagulation | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003867 |
| response to stimulus | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000005743, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000008717, ENSAPLP00000001720, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447 |
| cell part morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004998 |
| cell projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004998 |
| anatomical structure morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381, ENSAPLP00000004998 |
| cell adhesion | ENSAPLP00000003050, ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000000463 |
| biological adhesion | ENSAPLP00000003050, ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000000463 |
| organ morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle organ development | ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based movement | ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004998 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004998 |
| cell-substrate adhesion | ENSAPLP00000003050, ENSAPLP00000013787 |
| cell cycle phase transition | ENSAPLP00000000447, ENSAPLP00000007755 |
| mitotic cell cycle phase transition | ENSAPLP00000000447, ENSAPLP00000007755 |
| cell-cell junction organization | ENSAPLP00000009880, ENSAPLP00000003050 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000004998 |
| system development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000015662, ENSAPLP00000002381 |
| cell morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004998 |
| neuron differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000014548 |
| cellular process involved in reproduction | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000010726, ENSAPLP00000007620 |
| cellular component assembly | ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000014548, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000007755 |
| axon guidance | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of body fluid levels | ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003867 |
| viral reproduction | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| regulation of phosphate metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000014548 |
| multi-organism cellular process | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| regulation of phosphorus metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000014548 |
| viral infectious cycle | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| multi-organism process | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000002381 |
| inflammatory response | ENSAPLP00000003050, ENSAPLP00000005038 |
| response to metal ion | ENSAPLP00000009880, ENSAPLP00000003867 |
| platelet activation | ENSAPLP00000003050, ENSAPLP00000003867 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004998 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004998 |
| cell junction assembly | ENSAPLP00000009880, ENSAPLP00000008674 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004998 |
| regulation of lymphocyte activation | ENSAPLP00000003050, ENSAPLP00000005038 |
| protein polymerization | ENSAPLP00000003867, ENSAPLP00000007755 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004998 |
| M phase | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| cell migration | ENSAPLP00000003050, ENSAPLP00000008674, ENSAPLP00000007755 |
| regulation of cell migration | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| positive regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of locomotion | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| negative regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| positive regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000003219, ENSAPLP00000002711 |
| positive regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of cell motility | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| response to external stimulus | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711 |
| positive regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002711 |
| defense response | ENSAPLP00000003050, ENSAPLP00000007755, ENSAPLP00000005038 |
| axonogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| embryo development | ENSAPLP00000015078, ENSAPLP00000003050, ENSAPLP00000003219 |
| neuron projection development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell morphogenesis involved in neuron differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| neuron projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| cell motility | ENSAPLP00000003050, ENSAPLP00000008674, ENSAPLP00000007755 |
| regulation of cellular component movement | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219 |
| regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| localization of cell | ENSAPLP00000003050, ENSAPLP00000008674, ENSAPLP00000007755 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004998 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004998 |
| anatomical structure homeostasis | ENSAPLP00000016219, ENSAPLP00000001720 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004998 |
| chemotaxis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| tissue development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| taxis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| multicellular organismal process | ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000007755, ENSAPLP00000015662, ENSAPLP00000002381 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331 |
| neurogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| generation of neurons | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| chromosome organization | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000001720, ENSAPLP00000001729 |
| cellular response to chemical stimulus | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000014548 |
| developmental process | ENSAPLP00000013416, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000015078, ENSAPLP00000009880, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000004998, ENSAPLP00000002381 |
| multicellular organismal development | ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000015662, ENSAPLP00000002381 |
| cellular process | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000014331, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000009975, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001729, ENSAPLP00000014548, ENSAPLP00000003219, ENSAPLP00000010726, ENSAPLP00000016333, ENSAPLP00000013787, ENSAPLP00000016219, ENSAPLP00000003689, ENSAPLP00000005743, ENSAPLP00000015662, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000007755, ENSAPLP00000002381, ENSAPLP00000004998, ENSAPLP00000011000, ENSAPLP00000002711, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000000463 |
| nucleosome assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| heart development | ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004998 |
| chromatin assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004998 |
| cellular protein complex assembly | ENSAPLP00000003867, ENSAPLP00000007755 |
| tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of multicellular organismal process | ENSAPLP00000003050, ENSAPLP00000005743 |
| regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000005743 |
| cell morphogenesis involved in differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| RNA catabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331 |
| mRNA catabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331 |
| cellular component disassembly | ENSAPLP00000015078, ENSAPLP00000000447, ENSAPLP00000010726, ENSAPLP00000007620 |
| regulation of phosphorylation | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| positive regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| neuron development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050 |
| nuclear division | ENSAPLP00000013416, ENSAPLP00000007755 |
| chromatin assembly or disassembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| immune response | ENSAPLP00000007755, ENSAPLP00000005038 |
| mitosis | ENSAPLP00000013416, ENSAPLP00000007755 |
| response to biotic stimulus | ENSAPLP00000002711, ENSAPLP00000002381 |
| positive regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| nucleosome organization | ENSAPLP00000001720, ENSAPLP00000001729 |
| regulation of multi-organism process | ENSAPLP00000006303, ENSAPLP00000003050 |
| organelle fission | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of peptidase activity | ENSAPLP00000004358, ENSAPLP00000012216 |
| regulation of endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000012216 |
| protein-DNA complex assembly | ENSAPLP00000001720, ENSAPLP00000001729 |
| cellular macromolecular complex assembly | ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000007755, ENSAPLP00000001729 |
| homeostatic process | ENSAPLP00000015679, ENSAPLP00000016219, ENSAPLP00000001720, ENSAPLP00000015662 |
| system process | ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular membrane organization | ENSAPLP00000011000, ENSAPLP00000006303, ENSAPLP00000003050 |
| positive regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| membrane organization | ENSAPLP00000011000, ENSAPLP00000006303, ENSAPLP00000003050 |
| single-multicellular organism process | ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000007755, ENSAPLP00000015662, ENSAPLP00000002381 |
| response to organic substance | ENSAPLP00000004358, ENSAPLP00000008717, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000014548 |
| organ development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000002381 |
| M phase of mitotic cell cycle | ENSAPLP00000013416, ENSAPLP00000007755 |
| microtubule cytoskeleton organization | ENSAPLP00000013416, ENSAPLP00000007755 |
| rRNA processing | ENSAPLP00000015078, ENSAPLP00000015662 |
| rRNA metabolic process | ENSAPLP00000015078, ENSAPLP00000015662 |
| sexual reproduction | ENSAPLP00000013416, ENSAPLP00000011900 |
| positive regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003219 |
| protein-DNA complex subunit organization | ENSAPLP00000001720, ENSAPLP00000001729 |
| translational termination | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| response to abiotic stimulus | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000014548 |
| viral genome expression | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| viral transcription | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| reproduction | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000011900, ENSAPLP00000010726, ENSAPLP00000007620 |
| chromatin organization | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| protein complex disassembly | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| cellular protein complex disassembly | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| positive regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| response to inorganic substance | ENSAPLP00000009880, ENSAPLP00000003867 |
| positive regulation of cell death | ENSAPLP00000004358, ENSAPLP00000013972 |
| cellular homeostasis | ENSAPLP00000015679, ENSAPLP00000016219 |
| neurotrophin signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| positive regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000013972 |
| positive regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000013972 |
| neurotrophin TRK receptor signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| DNA metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729 |
| cell cycle phase | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| macromolecular complex disassembly | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| single-organism transport | ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755 |
| cellular nitrogen compound catabolic process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009975 |
| heterocycle catabolic process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009975 |
| organic cyclic compound catabolic process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009975 |
| single organism reproductive process | ENSAPLP00000013416, ENSAPLP00000011900 |
| positive regulation of protein kinase activity | ENSAPLP00000000447, ENSAPLP00000002711 |
| mitotic cell cycle | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| cotranslational protein targeting to membrane | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| negative regulation of signal transduction | ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000002711 |
| protein targeting to ER | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| protein localization to endoplasmic reticulum | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| cellular macromolecule catabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000014548 |
| nervous system development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000007755 |
| protein localization to organelle | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| response to organic cyclic compound | ENSAPLP00000008717, ENSAPLP00000014548 |
| negative regulation of developmental process | ENSAPLP00000001720, ENSAPLP00000005038 |
| cell division | ENSAPLP00000013416, ENSAPLP00000007755 |
| cardiovascular system development | ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003219, ENSAPLP00000002381 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| viral reproductive process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| protein targeting to membrane | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| negative regulation of cell communication | ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000002711 |
| negative regulation of signaling | ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000002711 |
| reproductive process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000010726, ENSAPLP00000007620 |
| macromolecular complex assembly | ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000001729 |
| multi-organism reproductive process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| ncRNA processing | ENSAPLP00000015078, ENSAPLP00000015662 |
| macromolecule catabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000014548 |
| intracellular protein transport | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| establishment of protein localization to organelle | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| protein targeting | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| cellular response to organic substance | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000014548 |
| chromatin modification | ENSAPLP00000012216, ENSAPLP00000001720 |
| response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000003050 |
| cellular response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000003050 |
| translational initiation | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| positive regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| negative regulation of response to stimulus | ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000002711 |
| cellular catabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| nucleobase-containing compound catabolic process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755, ENSAPLP00000014331 |
| apoptotic process | ENSAPLP00000004358, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000004358, ENSAPLP00000002381 |
| negative regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000005038 |
| protein complex assembly | ENSAPLP00000003867, ENSAPLP00000007755, ENSAPLP00000005038 |
| biological regulation | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000016219, ENSAPLP00000005743, ENSAPLP00000015662, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000015679, ENSAPLP00000013972, ENSAPLP00000002381, ENSAPLP00000004998, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000003219 |
| transport | ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000015078, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000004998 |
| aromatic compound catabolic process | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755, ENSAPLP00000014331 |
| establishment of localization | ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000015078, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000004998 |
| cellular response to stimulus | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000014548, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219 |
| negative regulation of biological process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000005743, ENSAPLP00000004998 |
| protein complex biogenesis | ENSAPLP00000003867, ENSAPLP00000007755, ENSAPLP00000005038 |
| cell death | ENSAPLP00000004358, ENSAPLP00000002381 |
| death | ENSAPLP00000004358, ENSAPLP00000002381 |
| ribosome biogenesis | ENSAPLP00000015078, ENSAPLP00000015662 |
| negative regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000005038 |
| positive regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| negative regulation of cell death | ENSAPLP00000004358, ENSAPLP00000005038 |
| localization | ENSAPLP00000013416, ENSAPLP00000008674, ENSAPLP00000011711, ENSAPLP00000015662, ENSAPLP00000006303, ENSAPLP00000015078, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000004998 |
| cellular response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000014548 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000005743 |
| organic substance catabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| transmembrane receptor protein tyrosine kinase signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| regulation of protein kinase activity | ENSAPLP00000000447, ENSAPLP00000002711 |
| cell cycle process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| signal transduction | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711 |
| negative regulation of cellular process | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000004998 |
| cellular protein localization | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| cellular macromolecule localization | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| nucleic acid metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726 |
| microtubule-based process | ENSAPLP00000013416, ENSAPLP00000007755 |
| enzyme linked receptor protein signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050 |
| ncRNA metabolic process | ENSAPLP00000015078, ENSAPLP00000015662 |
| regulation of protein metabolic process | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000002711 |
| catabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| regulation of cell death | ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000005038 |
| vesicle-mediated transport | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000004998 |
| regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000005038 |
| regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000005038 |
| signaling | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711 |
| single organism signaling | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711 |
| positive regulation of protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| cytoplasmic transport | ENSAPLP00000015078, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| cellular localization | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755 |
| regulation of multicellular organismal development | ENSAPLP00000003050, ENSAPLP00000001720 |
| intracellular transport | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755 |
| RNA biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| positive regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000005038 |
| regulation of developmental process | ENSAPLP00000003050, ENSAPLP00000001720, ENSAPLP00000005038 |
| translation | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000016333 |
| regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000002711 |
| positive regulation of cellular process | ENSAPLP00000013416, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000000447 |
| cell communication | ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711 |
| regulation of localization | ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005038 |
| translational elongation | ENSAPLP00000015078, ENSAPLP00000010726 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000015078, ENSAPLP00000015662 |
| regulation of cell cycle | ENSAPLP00000000447, ENSAPLP00000005038 |
| establishment of localization in cell | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000007755 |
| cell cycle | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| organonitrogen compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009975 |
| GTP catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| guanosine-containing compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000014548 |
| proteolysis | ENSAPLP00000013972, ENSAPLP00000002711, ENSAPLP00000014548 |
| response to endogenous stimulus | ENSAPLP00000008717, ENSAPLP00000014548 |
| protein transport | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| regulation of signal transduction | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000002711 |
| establishment of protein localization | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| positive regulation of biological process | ENSAPLP00000013416, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000000447 |
| proteolysis involved in cellular protein catabolic process | ENSAPLP00000002711, ENSAPLP00000014548 |
| macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000013972, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000016333 |
| cellular protein catabolic process | ENSAPLP00000002711, ENSAPLP00000014548 |
| GTP metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| guanosine-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| positive regulation of metabolic process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| cellular macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000016333 |
| regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000004998 |
| positive regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000005038 |
| positive regulation of signaling | ENSAPLP00000003050, ENSAPLP00000005038 |
| protein catabolic process | ENSAPLP00000002711, ENSAPLP00000014548 |
| nucleobase-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| purine nucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| nucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| nucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| ribonucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine ribonucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| glycosyl compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000003219 |
| RNA processing | ENSAPLP00000015078, ENSAPLP00000014331, ENSAPLP00000015662 |
| purine nucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine ribonucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| nucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| ribonucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| organophosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine-containing compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| nucleoside phosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of cell communication | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000002711 |
| mRNA metabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331 |
| cellular aromatic compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| carbohydrate derivative catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of signaling | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038, ENSAPLP00000002711 |
| heterocycle metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| regulation of transport | ENSAPLP00000003050, ENSAPLP00000005038 |
| cellular protein metabolic process | ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000004358, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000016333 |
| protein localization | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| organic substance transport | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| protein metabolic process | ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000015078, ENSAPLP00000004358, ENSAPLP00000013972, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000016333 |
| positive regulation of cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000002711 |
| cellular nitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009975 |
| organic cyclic compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| cell surface receptor signaling pathway | ENSAPLP00000006303, ENSAPLP00000003050, ENSAPLP00000005038 |
| RNA metabolic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000015662 |
| regulation of cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000000447 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| cellular response to stress | ENSAPLP00000003219, ENSAPLP00000002711 |
| purine nucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine ribonucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of primary metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000000447 |
| aromatic compound biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| nucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| heterocycle biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| nitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001729, ENSAPLP00000015662, ENSAPLP00000015078, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009975 |
| gene expression | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000015662, ENSAPLP00000016333 |
| ribonucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of biological process | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000016219, ENSAPLP00000005743, ENSAPLP00000004358, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000004998, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000000447 |
| purine nucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| nucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine ribonucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| purine-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| glycosyl compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| macromolecule localization | ENSAPLP00000015078, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007620 |
| ribonucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| ribose phosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| organic cyclic compound biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620 |
| macromolecule biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000016333 |
| cellular macromolecule biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000016333 |
| regulation of cellular process | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000016219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000006303, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013972, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000004998 |
| primary metabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000009975, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000016333 |
| intracellular signal transduction | ENSAPLP00000013416, ENSAPLP00000001720 |
| organonitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009975 |
| nucleoside phosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| nucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| carbohydrate derivative metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| organophosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000007755, ENSAPLP00000009975, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000016333 |
| organic substance metabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000009975, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000016333 |
| small molecule metabolic process | ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000009975 |
| regulation of macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000002711 |
| cellular biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000016333 |
| metabolic process | ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000009880, ENSAPLP00000004358, ENSAPLP00000015078, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000009975, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001729, ENSAPLP00000002711, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000007620, ENSAPLP00000010726, ENSAPLP00000016333 |
| organic substance biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000016333 |
| biosynthetic process | ENSAPLP00000015078, ENSAPLP00000010726, ENSAPLP00000007620, ENSAPLP00000005038, ENSAPLP00000016333 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000016219, ENSAPLP00000002711 |
| single-organism metabolic process | ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000009975 |
| phosphorus metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| phosphate-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000016219, ENSAPLP00000002711 |
| regulation of gene expression | ENSAPLP00000013416, ENSAPLP00000007620, ENSAPLP00000016219, ENSAPLP00000005038 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000013416, ENSAPLP00000007620, ENSAPLP00000016219 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000013416, ENSAPLP00000007620, ENSAPLP00000016219 |
| regulation of transcription, DNA-dependent | ENSAPLP00000013416, ENSAPLP00000016219 |
| regulation of cellular biosynthetic process | ENSAPLP00000013416, ENSAPLP00000007620, ENSAPLP00000016219 |
| regulation of RNA biosynthetic process | ENSAPLP00000013416, ENSAPLP00000016219 |
| regulation of biosynthetic process | ENSAPLP00000013416, ENSAPLP00000007620, ENSAPLP00000016219 |
| regulation of RNA metabolic process | ENSAPLP00000013416, ENSAPLP00000016219 |
|